Titan Pharmaceuticals
TTNP
#10473
Rank
HK$47.99 M
Marketcap
HK$36.08
Share price
-3.76%
Change (1 day)
16.91%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.36. In 2023 the company made an earnings per share (EPS) of -HK$58.00 an increase over its 2022 EPS that were of -HK$118.89.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$58.00-51.22%
2022-HK$118.89-15.61%
2021-HK$140.89-81.37%
2020-HK$756.10-77.52%
2019-HK$3,364-56.32%
2018-HK$7,702-59.51%
2017-HK$19,024-371.81%
2016HK$6,999-144.35%
2015-HK$15,780300%
2014-HK$3,945-121.54%
2013HK$18,316-151.38%
2012-HK$35,645-11.54%
2011-HK$40,294188.89%
2010-HK$13,948-10%
2009-HK$15,498
2007-HK$63,541-2.38%
2006-HK$65,091-39.13%
2005-HK$106,935-16.87%
2004-HK$128,632-22.43%
2003-HK$165,8274.9%
2002-HK$158,07861.9%
2001-HK$97,636-13.7%
2000-HK$113,13465.01%
1999-HK$68,563-35.87%
1998-HK$106,917-1824.71%
1997HK$6,199-102.4%
1996-HK$258,814

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.18-353.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$56.36-264.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$11.11-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$6.81-119.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.96-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$30.45-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA